Yoshiko Takeda‐Uchimura

Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins

Sandip Ray, Markus Britschgi, Charles Herbert et al. · Nature Medicine · 2007 · 1.1K citations

Alzheimer's Disease, Medicine, Dementia +11

Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's disease

Markus Britschgi, Christopher E. Olin, Hudson Johns et al. · Proceedings of the National Academy of Sciences · 2009 · 196 citations · Full text

Peptide Engineering, Amyloidogenic Peptides Decrease, Immunology +17

Deficiency of terminal complement pathway inhibitor promotes neuronal tau pathology and degeneration in mice

Markus Britschgi, Yoshiko Takeda‐Uchimura, Edward Rockenstein et al. · Journal of Neuroinflammation · 2012 · 51 citations · Full text

Deficiency of a sulfotransferase for sialic acid-modified glycans mitigates Alzheimer’s pathology

Zui Zhang, Yoshiko Takeda‐Uchimura, Tahmina Foyez et al. · Proceedings of the National Academy of Sciences · 2017 · 48 citations · Full text

Microglial Keratan Sulfate Epitope Elicits in Central Nervous Tissues of Transgenic Model Mice and Patients with Amyotrophic Lateral Sclerosis

Tahmina Foyez, Yoshiko Takeda‐Uchimura, Shinsuke Ishigaki et al. · American Journal Of Pathology · 2015 · 43 citations · Full text

Neurodegenerative Diseases, Amyotrophic Lateral Sclerosis, Medicine +10